porcin
reproduct
respiratori
syndrom
prr
immunosuppress
chronic
respiratori
viral
diseas
pig
respons
major
econom
loss
swine
industri
worldwid
efficaci
parenter
administr
wide
use
modifi
live
viru
prr
vaccin
prrsmlv
genet
diverg
prrsv
strain
remain
question
therefor
evalu
altern
proven
mucos
immun
approach
intranas
deliveri
prrsmlv
strain
potent
adjuv
elicit
crossprotect
immun
heterolog
prrsv
strain
mycobacterium
tuberculosi
whole
cell
lysat
mtb
wcl
chosen
potent
mucos
adjuv
due
bias
immun
respons
prrsmlv
unvaccin
pig
challeng
clinic
prr
sever
lung
patholog
howev
vaccin
prrsmlv
mtb
wcl
pig
challeng
appar
healthi
signific
increas
bodi
weight
gain
vaccin
compar
unvaccin
prrsv
challeng
pig
vaccin
compar
unvaccin
viruschalleng
pig
reduc
lung
patholog
associ
enhanc
prrsv
neutral
antibodi
titer
reduc
viremia
immunolog
increas
frequenc
th
cell
thmemori
cell
cell
dendrit
cell
activ
th
cell
reduc
frequenc
tregulatori
cell
detect
mucos
system
site
reduc
secret
immunosuppress
cytokin
upregul
cytokin
blood
lung
detect
mucos
vaccin
prrsvchalleng
pig
conclus
intranas
immun
pig
prrsmlv
administ
mtb
wcl
gener
effect
crossprotect
immun
prrsv
porcin
reproduct
respiratori
syndrom
prr
chronic
immunosuppress
diseas
pig
respons
huge
econom
loss
swine
industri
worldwid
econom
impact
prr
alon
us
swine
produc
estim
approxim
million
annual
accord
anim
plant
health
inspect
servic
aphi
report
januari
overal
unvaccin
growerfinish
pig
posit
prrsv
antibodi
us
http
wwwaphi
usdagovanim
prrspdf
member
arterivirida
famili
prrsv
contain
positivesens
singlestrand
rna
genom
prrsv
caus
respiratori
distress
pig
age
reproduct
failur
sow
infect
viru
result
suppress
innat
immun
respons
reduc
product
nk
cell
cytotox
delay
onset
adapt
immun
respons
differ
field
isol
prrsv
found
carri
variabl
level
genet
divers
rang
one
virul
strain
antigen
highli
diverg
vaccin
strain
current
modifi
live
inactiv
prrsv
vaccin
licens
use
howev
vaccin
alway
efficaci
prevent
prrsv
reinfect
transmiss
continu
question
regard
vaccin
safeti
efficaci
exist
well
emerg
antigen
heterolog
prrsv
strain
therefor
develop
broadli
protect
prrsv
vaccin
challeng
prrsv
research
recent
prrsv
expert
research
collect
agre
replic
prrsv
vaccin
promis
field
success
protect
achiev
improv
efficaci
live
prrsv
vaccin
http
vetmedillinoisedunew
prrswhitepaperpdf
mucos
surfac
cover
largest
surfac
area
bodi
almost
total
immun
cell
bodi
local
mucosaassoci
lymphoid
tissu
malt
mucos
site
nasopharyng
malt
contain
entir
repertoir
immun
cell
strateg
locat
orchestr
region
immun
function
airborn
infect
major
pathogen
transmit
mucos
surfac
caus
diseas
primarili
mucos
site
eg
influenza
prrsv
hiv
rotaviru
etc
demonstr
system
stimul
immun
system
mainli
result
system
protect
low
mucos
immun
respons
convers
optim
stimul
mucos
immun
system
gener
mucos
system
immun
mucos
immun
system
possess
strong
immunoregulatori
mechan
dampen
inflammationinduc
patholog
therefor
mucos
immun
gener
result
toler
absenc
suitabl
adjuv
deliveri
system
intranas
deliveri
live
attenu
vaccin
bovin
herp
influenza
administ
adjuv
proven
effect
intranas
deliveri
influenza
vaccin
potent
adjuv
result
effect
cross
protect
due
immun
respons
gener
conserv
intern
viral
protein
thu
mucos
immun
may
attract
method
induc
prrsv
specif
crossprotect
immun
design
effect
mucos
vaccin
easi
adjuvantdeliveri
system
use
must
elicit
toxic
overcom
hostandor
vaccin
antigensinduc
immunosuppress
heatkil
mycobacterium
tuberculosi
mtb
oil
emuls
use
extens
experiment
purpos
complet
freund
adjuv
unfortun
advers
effect
mediat
major
cell
wall
compon
mtb
mycol
acid
peptidoglycan
wax
preclud
use
complet
freund
adjuv
human
food
anim
adjuvant
variou
purifi
individu
compon
mtb
investig
includ
water
solubl
whole
cell
lysat
wcl
mtb
interestingli
mtb
wcl
fraction
heat
shock
pe
proglu
ppe
proproglu
identifi
elicit
potent
adjuv
activ
howev
knowledg
relat
mucos
adjuvant
mtb
wcl
mucos
viral
vaccin
limit
initi
perform
studi
choos
suitabl
bacteri
candid
mucos
adjuv
use
prrsmlv
pig
inocul
intranas
nine
differ
bacteri
prepar
belong
mycobacterium
vibrio
streptococcu
select
mtb
wcl
due
abil
induc
increas
reduc
immunosuppress
respons
detail
result
publish
elsewher
subsequ
prrsv
specif
immun
respons
mtb
wcl
pig
inocul
intranas
evalu
detail
prechalleng
studi
result
satisfactori
immun
correl
protect
mediat
mtb
wcl
purpos
current
studi
confirm
mucos
adjuvant
mtb
wcl
prrsmlv
induc
effect
crossprotect
challeng
genet
diverg
virul
prrsv
strain
stabl
mycoplasmafre
cell
support
growth
prrsv
use
prepar
prrsv
stock
perform
immunolog
assay
cell
maintain
dmem
fb
atlanta
biolog
lawrencevil
ga
c
convent
larg
whiteduroc
crossbr
wean
specificpathogenfre
piglet
wk
age
transport
anim
facil
food
anim
health
research
program
ohio
agricultur
research
develop
center
wooster
oh
swine
herd
confirm
seroneg
antibodi
prrsv
porcin
respiratori
corona
viru
transmiss
gastroenter
viru
porcin
circo
viru
piglet
bled
arriv
sera
test
confirm
absenc
prrsv
antibodi
pig
allow
acclim
addit
week
initi
experi
anim
maintain
larg
anim
facil
supervis
veterinarian
throughout
durat
studi
anim
receiv
food
water
ad
libitum
inocul
adjuv
mtb
wcl
mgpig
vaccin
prrsmlv
tcid
per
pig
challeng
prrsv
tcid
per
pig
administ
intranas
adjuv
vaccin
inocul
separ
nostril
pig
maintain
sampl
collect
euthan
per
protocol
approv
institut
anim
care
use
committe
iacuc
wooster
institut
biosafeti
committe
ibc
columbu
ohio
state
univers
ohio
primari
studi
pig
randomli
alloc
one
three
group
group
mock
pig
n
receiv
dmem
unvaccin
unchalleng
group
unvaccin
pig
n
group
vaccin
prrsmlv
mtb
wcl
pig
n
group
challeng
prrsv
day
postvaccin
dpv
three
pig
group
euthan
day
postchalleng
dpc
mock
inocul
pig
n
euthan
separ
prior
kill
infect
anim
anoth
studi
total
nine
pig
split
three
group
hous
three
separ
isol
room
n
per
group
pig
inocul
intranas
follow
group
mock
dmem
group
vaccin
prrsmlv
group
vaccin
adjuv
prrsmlv
mtb
wcl
group
challeng
prrsv
dpv
infect
allow
proceed
day
time
pig
euthan
mock
inocul
pig
euthan
prior
euthanasia
prrsv
challeng
anim
blood
ml
collect
dpi
dpc
serum
separ
clot
blood
aliquot
serum
preserv
c
use
assay
serum
use
evalu
viremia
viral
titer
prrsv
serum
neutral
antibodi
titer
cytokin
product
pig
monitor
daili
respiratori
diseas
rectal
temperatur
bodi
weight
record
twice
week
blood
collect
acid
citrat
dextros
solut
process
isol
peripher
blood
mononuclear
cell
pbmc
previous
describ
lung
mononuclear
cell
lung
mnc
individu
pig
isol
necropsi
describ
previous
tracheobronchi
lymph
node
tbln
drain
lung
collect
dmem
cut
small
piec
homogen
stainless
steel
cellector
homogen
wash
pellet
dissolv
rpmi
contain
percol
centrifug
min
g
c
brake
red
blood
cell
cell
pellet
lyse
mononuclear
cell
wash
resuspend
enrich
rpmi
fetal
bovin
serum
gentamicin
gml
ampicillin
gml
mm
hepe
mm
lglutamin
mm
nonessenti
amino
acid
mm
sodium
pyruv
nm
necropsi
perform
lung
tonsil
tbln
examin
gross
lesion
grossli
evid
pulmonari
chang
assign
score
base
upon
percent
virusaffect
lesion
purpler
color
consolid
lung
lobe
total
score
entir
lung
calcul
describ
previous
analys
perform
use
standard
indirect
immunofluoresc
assay
ifa
describ
previous
viru
titrat
confluent
monolay
cell
microtit
plate
incub
dilut
serum
h
determin
viru
neutral
vn
titer
serum
heat
treat
complement
inactiv
dilut
twofold
dmem
incub
equal
volum
prrsv
contain
tcid
per
well
h
c
one
hundr
microlit
suspens
transfer
microtit
plate
contain
confluent
monolay
cell
incub
h
c
co
incub
cytopath
effect
examin
follow
fixat
aceton
water
addit
antipprsv
nucleoprotein
mab
clone
rural
technolog
inc
brook
sd
conjug
antimous
igg
hl
secondari
antibodi
observ
fluoresc
microscop
mount
glycerolpb
ratio
five
million
pbmc
tbln
mnc
lung
mnc
subject
vitro
restimul
tissu
cultur
plate
presenc
kill
crude
prrsv
antigen
ag
gml
recombin
prrsv
carboxi
termin
amino
acid
fragment
matrix
protein
gml
enrich
rpmi
h
c
harvest
cultur
supernat
analyz
cytokin
elisa
cell
cultur
absenc
antigen
includ
control
amount
cytokin
secret
cell
subtract
respect
restimul
experiment
well
valu
frequenc
cell
pbmc
determin
elispot
assay
describ
previous
briefli
pbmc
plate
cellswel
enrich
rpmi
multiscreen
plate
millipor
billerica
precoat
overnight
mous
antipig
mab
bd
pharmingen
san
diego
ca
c
cell
restimul
kill
crude
prrsv
ag
gml
h
c
co
incub
plate
incub
biotinyl
antipig
detect
antibodi
subsequ
streptavidinhrp
conjug
develop
use
insolubl
substrat
tetramethylbenzidin
h
peroxidas
substrat
system
kpl
inc
gaithersburg
maryland
frequenc
prrsv
specif
cell
count
use
aid
elispot
reader
system
background
valu
subtract
respect
count
unstimul
cell
immun
respons
express
number
cell
per
million
pbmc
cell
stimul
phytohemaglutininp
includ
posit
control
everi
plate
pig
sera
collect
indic
dpc
cultur
supernat
harvest
vitro
restimul
pbmc
tbln
lung
mnc
analyz
elisa
secret
differ
interleukin
il
class
proinflammatori
immunosuppress
cytokin
describ
previous
flow
cytometr
analysi
perform
determin
phenotyp
frequenc
differ
immun
cell
multicolor
immunoassay
describ
previous
briefli
previous
isol
cell
type
pbmc
lung
mnc
tbln
mnc
treat
pig
serum
block
fc
receptor
cell
stain
appropri
mab
either
directli
conjug
specif
fluorochrom
biotinyl
purifi
antibodi
pig
specif
immun
cell
surfac
marker
southernbiotech
birmingham
alabama
bd
pharmingen
sla
class
ii
serotec
raleigh
nc
vmrd
pullman
wa
ebiosci
san
diego
ca
respect
isotyp
control
mab
label
cell
treat
streptavidinconjug
fluorochrom
respect
antispeci
isotyp
specif
secondari
antibodi
conjug
fluorochrom
final
cell
fix
paraformaldehyd
intracellular
stain
cell
surfac
stain
describ
overnight
incub
c
permeabil
buffer
stain
fluorochromeconjug
pig
crossreact
antirat
mab
immunostain
cell
acquir
use
fac
ariaii
bd
bioscienc
san
jose
ca
flow
cytomet
analysi
perform
determin
differ
immun
cell
popul
base
cell
surfac
marker
phenotyp
natur
killer
nk
cell
thelper
cell
cytotox
lymphocyt
ctl
doubl
posit
cell
also
call
thelpermemori
cell
cell
tregulatori
cell
myeloid
cell
activ
thelper
cell
dendrit
cell
rich
fraction
slaii
use
flowjo
softwar
tree
star
inc
usa
frequenc
individu
lymphocyt
myeloid
cell
subset
analyz
total
event
data
express
mean
valu
three
six
nine
pig
sem
statist
analys
perform
use
nonparametr
wilcoxon
ttest
function
compar
two
studi
group
unvaccin
vs
vaccin
fig
tabl
prrsmlv
vs
prrsmlv
mtb
wcl
nonparametr
kruskalw
test
follow
dunn
test
multipl
comparison
compar
three
group
vn
titer
bodi
weight
gain
use
sa
softwar
sa
institut
inc
cari
nc
statist
signific
assess
p
studi
pig
either
unvaccin
vaccin
prrsmlv
mtb
wcl
challeng
use
virul
heterolog
prrsv
clinic
unvaccin
pig
develop
typic
prr
symptom
fever
mild
cough
reduc
food
intak
lethargi
first
wk
postchalleng
vaccin
challeng
pig
suffer
clinic
prr
mean
bodi
temperatur
unvaccin
prrsv
challeng
pig
n
dpc
f
higher
compar
vaccin
pig
pig
vaccin
challeng
signific
increas
net
bodi
weight
gain
compar
control
challeng
pig
fig
unvaccin
challeng
pig
sever
gross
lung
lesion
ventral
dorsal
surfac
fig
lung
lesion
score
significantli
higher
dpc
dpc
compar
vaccin
challeng
pig
fig
protect
mucos
vaccin
pig
prrsv
challeng
associ
significantli
reduc
viral
load
fig
viral
titer
fig
dpc
circul
prrsv
blood
less
statist
signific
dpc
vaccin
pig
almost
clear
dpc
pig
group
fig
prrsv
neutral
antibodi
titer
serum
differ
time
point
dpc
analyz
signific
increas
vn
titer
vaccin
challeng
pig
detect
fig
found
signific
differ
vn
titer
vaccin
pig
dpc
titer
compar
dpc
mucos
vaccin
prrsvchalleng
pig
signific
reduct
serum
level
dpc
fig
similarli
serum
level
also
significantli
reduc
later
stage
challeng
dpc
fig
overal
immunosuppress
cytokin
detect
reduc
level
vaccin
pig
fig
c
inform
regard
secret
cytokin
pig
mnc
prrsv
restimul
ex
vivo
import
understand
viru
specif
memori
immun
respons
consist
reduc
lung
lesion
viremia
significantli
increas
frequenc
tabl
frequenc
immun
cell
pig
inocul
intranas
mock
vaccin
challeng
unvaccin
n
vaccin
prrsmlv
mtb
wcl
n
challeng
prrsv
secret
cell
pbmc
vaccin
prrsv
challeng
pig
dpc
detect
fig
trend
note
cell
lung
dpc
data
shown
concomit
reduct
lung
mnc
fig
extend
clinic
protect
vaccin
prrsv
challeng
pig
indic
increas
trend
secret
concomit
reduct
secret
lung
mnc
pbmc
dpc
data
shown
evalu
frequenc
variou
immun
cell
mucos
lung
tbln
mnc
system
site
pbmc
vaccin
virul
prrsv
challeng
pig
import
associ
cytokin
respons
dpc
signific
increas
frequenc
dendrit
cell
dc
increas
frequenc
th
cell
thmemori
cell
cell
detect
lung
vaccin
viru
challeng
pig
tabl
addit
pbmc
tbln
mnc
signific
increas
frequenc
activ
th
cell
detect
dpc
tabl
c
dpc
reduct
frequenc
tregulatori
cell
treg
lung
tbln
vaccin
viru
challeng
pig
detect
tabl
c
blood
tbln
frequenc
th
cell
significantli
increas
vaccin
pig
tabl
c
dpc
signific
decreas
frequenc
treg
lung
blood
detect
tabl
b
addit
significantli
increas
frequenc
dc
blood
detect
vaccin
prrsv
challeng
pig
dpc
tabl
strengthen
data
superior
adjuvant
mtb
wcl
prrsmlv
perform
challeng
studi
pig
vaccin
intranas
prrsmlv
presenc
absenc
mtb
wcl
prrsv
specif
vn
titer
detect
significantli
higher
level
dpc
pig
vaccin
prrsmlv
mtb
wcl
compar
prrsmlv
alon
fig
viru
neutral
antibodi
titer
present
low
level
pig
vaccin
prrsmlv
mtb
wcl
dpi
dpc
pig
group
receiv
prrsmlv
alon
fig
support
adjuv
mtb
wcl
mediat
enhanc
cell
mediat
immun
cmi
respons
prrsv
lung
mnc
pig
vaccin
mtb
wcl
secret
significantli
higher
amount
follow
restimul
use
ag
fig
anoth
respons
induc
cytokin
also
secret
significantli
higher
level
mtb
wcl
depend
manner
vaccin
pig
fig
expect
immunosuppress
cytokin
secret
significantli
reduc
level
pig
vaccin
mtb
wcl
compar
pig
vaccin
without
mtb
wcl
follow
challeng
prrsv
fig
frequenc
immun
cell
popul
also
evalu
mucos
system
site
two
pig
group
determin
mtb
wcl
mediat
adjuv
effect
lung
mnc
signific
increas
frequenc
th
cell
activ
th
cell
nk
cell
detect
challeng
pig
vaccin
prrsmlv
mtb
wcl
compar
pig
vaccin
prrsmlv
alon
tabl
pbmc
signific
increas
frequenc
cell
detect
prrsmlv
mtb
wcl
inocul
pig
tabl
expect
frequenc
treg
significantli
reduc
pbmc
tbln
mnc
pig
inocul
vaccin
mtb
wcl
compar
vaccin
alon
tabl
c
overal
data
particular
pig
group
combin
studi
demonstr
superior
adjuvant
mucos
adjuv
mtb
wcl
prrsmlv
per
knowledg
success
attempt
made
elicit
effect
antiprrsv
immun
intranas
deliveri
live
prrsv
vaccin
virus
evad
host
immun
promot
secret
antagon
protect
immun
respons
prrsv
induc
strong
immunosuppress
respons
result
delay
onset
cell
mediat
immun
respons
live
inactiv
prrsv
significantli
increas
gene
express
increas
concentr
pig
lung
detect
prrsvinfect
pig
long
period
time
nonetheless
express
gene
also
increas
pig
vaccin
prrsv
system
rout
prechalleng
studi
increas
secret
lung
blood
pig
vaccin
intranas
prrsmlv
without
mtb
wcl
detect
contrast
preand
postchalleng
studi
prrsmlv
inocul
intranas
mtb
wcl
secret
suppress
infiltr
treg
infect
pig
lung
contribut
secret
high
level
role
treg
establish
chronic
persist
hiv
hepat
c
b
virus
cytomegaloviru
epsteinbarr
viru
infect
report
like
mice
human
cell
compar
immunosuppress
properti
identifi
pig
studi
report
prrsv
mediat
prolifer
treg
infect
pig
indic
involv
diseas
progress
studi
consist
reduc
frequenc
treg
lung
blood
tbln
pig
vaccin
intranas
prrsmlv
mtb
wcl
detect
associ
reduc
secret
immunosuppress
cytokin
coordin
immunosuppress
function
treg
report
prrsv
increas
express
myeloid
cell
essenti
de
novo
induct
regul
differenti
function
treg
mice
human
pig
mucos
site
interconnect
common
mucos
immun
system
immun
one
primari
site
stimul
prolifer
migrat
antigenspecif
lymphocyt
result
mucos
system
immun
viru
neutral
antibodi
play
import
role
clearanc
prr
viremia
like
natur
prrsv
infect
prrsv
vaccin
also
induc
delay
neutral
antibodi
cmi
respons
pig
howev
increas
prrsvvn
titer
concomit
reduct
prrsv
load
pig
vaccin
prrsmlv
mtb
wcl
challeng
detect
studi
suggest
reduc
viremia
detect
vaccin
pig
correl
increas
prrsv
specif
vn
titer
apart
effect
humor
respons
potent
cmi
respons
essenti
complet
viral
clearanc
key
cytokin
associ
host
cmi
respons
produc
nk
cell
cell
th
cell
ctl
thmemori
cell
studi
reduc
clinic
prr
viremia
pig
vaccin
prrsmlv
mtb
wcl
associ
increas
frequenc
cell
increas
level
activ
th
cell
memoryth
cell
nk
cell
lung
blood
doubl
posit
cell
possess
memori
thelper
cytolyt
properti
gener
call
thmemori
cell
also
secret
import
cell
subset
associ
protect
pig
vaccin
pseudorabi
viru
recent
recombin
bcg
base
respiratori
synciti
viru
vaccin
induc
enhanc
recruit
cell
lung
result
increas
cytokin
respons
protect
vivo
adjuv
effect
water
solubl
fraction
mtb
wcl
contain
result
rapid
prolong
activ
antigenspecif
cell
consist
studi
mtb
wclmediat
increas
frequenc
cell
reduc
frequenc
treg
detect
importantli
associ
enhanc
secret
cytokin
downregul
secret
immunosuppress
cytokin
proinflammatori
cytokin
critic
induct
specif
adapt
immun
excess
secret
result
inflammationinduc
patholog
prechalleng
studi
increas
secret
lung
blood
prrsmlv
mtb
wcl
inocul
pig
dpv
associ
enhanc
prrsv
specif
cmi
respons
contrast
current
studi
reduc
gross
lung
lesion
observ
vaccin
challeng
pig
associ
reduc
secret
data
suggest
adjuv
mtb
wcl
mediat
regul
secret
might
play
role
induc
prrsvspecif
cmi
respons
pig
possess
higher
frequenc
cell
cell
consid
import
innat
immun
cell
mucos
site
addit
pig
nonmhc
class
cytolyt
activ
prrsv
infect
mucos
vaccin
prrsv
challeng
pig
increas
frequenc
cell
blood
lung
tbln
mediat
mtb
wcl
detect
suggest
possibl
protect
role
play
cell
prrsv
pig
summari
mucos
immun
pig
use
live
prrsv
vaccin
along
potent
adjuv
potenti
induc
heighten
innat
adapt
immun
respons
concomit
reduct
immunosuppress
respons
thu
base
immun
correl
protect
detect
virul
heterolog
prrsv
pig
intranas
vaccin
prrsmlv
mtb
wcl
may
possibl
achiev
effect
crossprotect
immun
ppr
futur
aim
conduct
field
trial
evalu
efficaci
mucos
immun
approach
control
prr
